Top Markets
Coin of the day
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Corporation

NYMX
Classement en actions #23483
Nymox Pharmaceutical Corporation operates as a biopharmaceutical firm,... Nymox Pharmaceutical Corporation operates as a biopharmaceutical firm, primarily focused on the discovery and advancement of medications for the aging population across Canada, the United States, Europe, and other international regions. The company's leading experimental compound is Fexapotide Triflutate (NX-1207), which has successfully concluded Phase III clinical trials for benign prostatic hyperplasia treatment. It has also completed Phase II trials for localized low-grade prostate cancer and is currently in preclinical studies for hepatocellular carcinoma. In addition to its drug pipeline, Nymox develops and markets diagnostic products. These include NicAlert and TobacAlert, tests that utilize urine or saliva samples to identify the use of tobacco products. The company further offers AlzheimAlert, a proprietary urine-based assay designed to aid healthcare professionals in diagnosing Alzheimer's disease. Alongside this diagnostic tool, Nymox is actively researching and developing therapeutic treatments for Alzheimer's disease. Founded in 1989, the company is headquartered in Nassau, the Bahamas.
Prix de l'action
$0.977
Dernière synchronisation: 2023-08-11
Capitalisation boursière
$72.98M
Changement (1 jour)
4.94%
Changement (1 an)
0.00%
Pays
BS
Échange Nymox Pharmaceutical Corporation (NYMX)

Catégorie

Historique du prix de l'action pour Nymox Pharmaceutical Corporation (NYMX)
Prix de clôture le plus élevé : $0.99 le 2023-08-01

Prix de clôture le plus bas : $6.33 le 1997-11-01
Historique du prix de l'action de Nymox Pharmaceutical Corporation de 1997 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 151.39%
2022 -66.65%
2021 -48.99%
2020 9.87%
2019 34.83%
2018 -54.85%
2017 16.78%
2016 -15.16%
2015 708.48%
2014 -93.14%
2013 -9.25%
2012 -13.68%
2011 50.92%
2010 17.92%
2009 47.20%
2008 -48.95%
2007 74.88%
2006 62.86%
2005 -26.81%
2004 -2.76%
2003 -25.35%
2002 1.15%
2001 147.59%
2000 -46.71%
1999 -43.98%
1998 -24.06%
1997 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH